Free shipping on all orders over $ 500

PFI-3

Cat. No. M9144

All AbMole products are for research use only, cannot be used for human consumption.

PFI-3 Structure
Size Price Availability Quantity
5mg USD 88  USD88 In stock
10mg USD 160  USD160 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PFI-3 is a selective, potent and cell-permeable SMARCA2/4 bromodomain inhibitor with a Kd of 89 nM. PFI-3 is a potent, cell-permeable probe capable of displacing ectopically expressed, GFP-tagged SMARCA2-bromodomain from chromatin. Stability measurements confirmed that PFI-3 has a half-life in aqueous solutions exceeding 7 days at 37°C. In long-term experiments, PFI-3 significantly altered gene expression programs that are important for differentiation of stem cells. PFI-3 mimics the effect of Brg1 deletion, resulting in an increase of the repressive H3K27me3 mark at the TSSs and Stat3 binding sites of these genes. PFI-3 has a half-life of >250 h in PBS, pH 7.4, at 20 °C.

Chemical Information
Molecular Weight 321.37
Formula C19H19N3O2
CAS Number 1819363-80-8
Solubility (25°C) DMSO: ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yali He, et al. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells

[2] Chuanhe Yang, et al. Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma

[3] Daye Lee, et al. The Bromodomain Inhibitor PFI-3 Sensitizes Cancer Cells to DNA Damage by Targeting SWI/SNF

[4] Mayumi Kobayashi-Kato, et al. Platinum-free interval affects efficacy of following treatment for platinum-refractory or -resistant ovarian cancer

[5] Bhavatarini Vangamudi, et al. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Related Epigenetic Reader Domain Products
dBRD9 dihydrochloride 

dBRD9 dihydrochloride is a selective BRD9 PROTAC degrader.

BBC0403 

BBC0403 is a selective BRD2 inhibitor with Kds of 7.64 μM and 41.37 μM for BRD2 (BD2) and BRD2 (BD1), respectively.

BAY-155 

BAY-155 is a potent and selective menin-MLL tool inhibitor, with an IC50 of 8 nM.

FHT-1015 

FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC50s of ≤10 nM.

ISOX-DUAL 

ISOX-DUAL is a dual CBP/BRD4 inhibitor with IC50 values of 0.65 μM and 1.5 μM for CBP and BRD4, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: PFI-3 supplier, Epigenetic Reader Domain, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.